Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07364981

Gaze Contingent Attentional Reinforcement in Major Depressive Disorder

Gaze Contingent Attentional Reinforcement Treatment of MDD

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Tel Aviv University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The main objective of this randomized controlled trial is to evaluate whether a gaze-contingent feedback task using negative reinforcement can serve as an effective attention-modification procedure and contribute to the treatment of Major Depressive Disorder (MDD).

Detailed description

This randomized controlled trial uses a gaze-contingent attentional reinforcement task to modify attention allocation patterns to emotional stimuli in participants with Major Depressive Disorder. Specifically, participants will undergo 4 training sessions, during which either negative reinforcement (aversive white noise will be heard when gazing at sad faces) or positive reinforcement (music will be heard when gazing at happy faces) will be used to divert participants' gaze toward happy faces and away from sad faces. Depressive symptoms severity will be assessed before and after training (post-training and 3-month follow up) to examine changes (reduction) in symptom severity from before to after the intervention. Attention allocation will be assessed during training (i.e. online learning) as well as before and after training (i.e. transfer of learning).

Conditions

Interventions

TypeNameDescription
BEHAVIORALAversive white noiseParticipants will receveve gaze-contingent negative-reinforcement feedback according to their viewing patterns, such that when gazing at the target stimuli (i.e., happy faces) the noise will stop.
BEHAVIORALMusic rewardParticipants will receive gaze-contingent music-reward according to their viewing patterns, such that when gazing at the target stimuli (i.e., happy faces) the music will play.

Timeline

Start date
2026-01-01
Primary completion
2030-01-01
Completion
2030-01-01
First posted
2026-01-23
Last updated
2026-01-23

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT07364981. Inclusion in this directory is not an endorsement.